407 related articles for article (PubMed ID: 21146894)
1. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J
J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894
[TBL] [Abstract][Full Text] [Related]
2. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.
Gao H; Li N; Wang JY; Zhang SC; Lin G
J Dig Dis; 2012 Jan; 13(1):33-9. PubMed ID: 22188914
[TBL] [Abstract][Full Text] [Related]
3. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
[TBL] [Abstract][Full Text] [Related]
4. Tusanqi and hepatic sinusoidal obstruction syndrome.
Wang JY; Gao H
J Dig Dis; 2014 Mar; 15(3):105-7. PubMed ID: 24528632
[TBL] [Abstract][Full Text] [Related]
5. The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica.
Chen Y; Xiong F; Wang W; Jiang K; Ye X; Deng G; Wang C; Yang L; Xiong A; Wang Z
Toxicol Lett; 2020 May; 323():41-47. PubMed ID: 31982501
[TBL] [Abstract][Full Text] [Related]
6. Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome.
Gao H; Ruan JQ; Chen J; Li N; Ke CQ; Ye Y; Lin G; Wang JY
Drug Des Devel Ther; 2015; 9():4861-8. PubMed ID: 26346783
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.
Ma J; Li M; Li N; Chan WY; Lin G
Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679016
[TBL] [Abstract][Full Text] [Related]
8. Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China.
Zhu L; Zhang CY; Li DP; Chen HB; Ma J; Gao H; Ye Y; Wang JY; Fu PP; Lin G
Acta Pharmacol Sin; 2021 Aug; 42(8):1212-1222. PubMed ID: 33154553
[TBL] [Abstract][Full Text] [Related]
9. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.
Zhang F; Zhou Y; Yang X; Xiong AZ; Wang ZT; Yang L
Acta Pharmacol Sin; 2019 Jun; 40(6):781-789. PubMed ID: 30367152
[TBL] [Abstract][Full Text] [Related]
10. Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.
Ou P; Liu X; Tang Z; Hou Z; Liu L; Liu J; Zhou S; Fang Z; Sun K; Chen Y; Chen X; Li Y; Chen J
Curr Pharm Des; 2019; 25(35):3762-3768. PubMed ID: 31589115
[TBL] [Abstract][Full Text] [Related]
11. Hepatic sinusoidal obstruction syndrome caused by the ingestion of
Cen P; Ding J; Jin J
J Int Med Res; 2021 Apr; 49(4):300060520980649. PubMed ID: 33845617
[TBL] [Abstract][Full Text] [Related]
12. Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yu XZ; Ji T; Bai XL; Liang L; Wang LY; Chen W; Liang TB
J Zhejiang Univ Sci B; 2013 Jan; 14(1):68-75. PubMed ID: 23303633
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.
Kan X; Ye J; Rong X; Lu Z; Li X; Wang Y; Yang L; Xu K; Song Y; Hou X
Sci Rep; 2016 Nov; 6():37998. PubMed ID: 27897243
[TBL] [Abstract][Full Text] [Related]
14. Proteomic study of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome in rats.
Li YH; Tai WC; Xue JY; Wong WY; Lu C; Ruan JQ; Li N; Wan TF; Chan WY; Hsiao WL; Lin G
Chem Res Toxicol; 2015 Sep; 28(9):1715-27. PubMed ID: 26280871
[TBL] [Abstract][Full Text] [Related]
15. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.
Yang XQ; Ye J; Li X; Li Q; Song YH
World J Gastroenterol; 2019 Jul; 25(28):3753-3763. PubMed ID: 31391770
[TBL] [Abstract][Full Text] [Related]
16. Blood Pyrrole-Protein Adducts--A Biomarker of Pyrrolizidine Alkaloid-Induced Liver Injury in Humans.
Ruan J; Gao H; Li N; Xue J; Chen J; Ke C; Ye Y; Fu PP; Zheng J; Wang J; Lin G
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2015; 33(4):404-21. PubMed ID: 26398275
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
Yang M; Ruan J; Fu PP; Lin G
Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
[TBL] [Abstract][Full Text] [Related]
18. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yao J; Wu J; Jia S; Shao J; Zhang X; Xu Z; Zhang H; Li H; Yao X
J Clin Lab Anal; 2022 Dec; 36(12):e24793. PubMed ID: 36447383
[TBL] [Abstract][Full Text] [Related]
19. Assessment of pyrrolizidine alkaloid-induced toxicity in an in vitro screening model.
Li YH; Kan WL; Li N; Lin G
J Ethnopharmacol; 2013 Nov; 150(2):560-7. PubMed ID: 24045176
[TBL] [Abstract][Full Text] [Related]
20. Hepatic veno-occlusive disease induced by Gymura segetum: report of two cases.
Dai HF; Gao Y; Yang M; Yu CH; Gu ZY; Chen WX
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):406-8. PubMed ID: 16911940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
